4processed
Form 4 — Insider Transaction
KalVista Pharmaceuticals, Inc.(KALV)
Filing Date
June 11, 2026
Accepted
June 11, 2026
Accession No.
0001815308-26-000006
CIK
0001348911
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Piekos Brian | Chief Financial Officer | Other | 21.7K | $0 | — | 0 | Common Stock | Jun 11, 2026 |
| Piekos Brian | Chief Financial Officer | Other | 100.0K | — | — | 0 | Stock Option (Right to Buy) | Jun 11, 2026 |
| Piekos Brian | Chief Financial Officer | Other | 55.0K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |
| Piekos Brian | Chief Financial Officer | Other | 93.8K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |